Drug Shortages Are A Matter Of Time As Bill Sponsors Work To Show Warnings Will Help
Supporters of pending legislation on drug shortages face a challenge of time – demonstrating that the extra time the advance-warning system would provide is worth the legislative time and effort to create it.
You may also be interested in...
Agency maintains its inspection policy does not cause or prevent shortages.
Senators also have requested a GAO study of the nature of drug shortages and FDA's ability to respond to them.
Congress is not expected to pile as many new responsibilities on FDA in the upcoming Prescription Drug User Fee Act reauthorization as in 2007’s FDA Amendments Act.